SCHEMBL178281

SCHEMBL178281

CCCC1CC(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12166761 0.88 EPHX2 (0.34)
SCHEMBL19823455 0.86 NOS3 (0.31)
SCHEMBL10409624 0.85 CA1 (0.41)
SCHEMBL25268467 0.83
SCHEMBL12166660 0.82
SCHEMBL12166566 0.82
SCHEMBL28403402 0.82 CA1 (0.42)
SCHEMBL14980930 0.81
SCHEMBL8223087 0.81
SCHEMBL8225002 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7608664-B2 Curable sealant composition and method for manufacturing same BRIDGESTONE CORPORATION (JP) 2009-10-27 US claimed
US-7517936-B2 Curable sealant composition BRIDGESTONE CORPORATION (JP) 2009-04-14 US claimed
US-20080161491-A1 Curable Sealant Composition and Method for Manufacturing Same BRIDGESTONE CORPORATION (JP) 2008-07-03 US claimed
EP-1611166-B1 BUILDING SEALANT COMPOSITION BRIDGESTONE CORP (JP) 2007-08-29 EP claimed
US-20060217489-A1 Building sealant composition BRIDGESTONE CORPORATION (JP) 2006-09-28 US claimed
WO-2006078756-A1 CURABLE SEALANT COMPOSITION AND METHOD FOR MANUFACTURING SAME BRIDGESTONE CORPORATION (JP) 2006-07-27 WO claimed
EP-1611166-A2 BUILDING SEALANT COMPOSITION Bridgestone Corporation (JP) 2006-01-04 EP claimed
WO-2004090060-A2 BUILDING SEALANT COMPOSITION BRIDGESTONE CORPORATION (JP) 2004-10-21 WO claimed
US-6737470-B1 POLYCONJUGATED DIENE WITH TRIALKOXYSILANE TERMINAL GROUPS; LOW POLYDISPERSITY; LOW COST; SINGLE PACKAGE BRIDGESTONE CORPORATION (JP) 2004-05-18 US claimed
WO-2019244066-A2 PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2019-12-26 WO disclosed
WO-2018071447-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed
WO-2016090285-A1 4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2016-06-09 WO disclosed
US-20120058997-A1 IMIDAZO[1,2-B]PYRIDAZINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS SUPERGEN, INC. (US) 2012-03-08 US disclosed
US-7608664-B2 Curable sealant composition and method for manufacturing same BRIDGESTONE CORPORATION (JP) 2009-10-27 US disclosed
EP-1611166-B1 BUILDING SEALANT COMPOSITION BRIDGESTONE CORP (JP) 2007-08-29 EP disclosed
US-20060217489-A1 Building sealant composition BRIDGESTONE CORPORATION (JP) 2006-09-28 US disclosed
WO-2006078756-A1 CURABLE SEALANT COMPOSITION AND METHOD FOR MANUFACTURING SAME BRIDGESTONE CORPORATION (JP) 2006-07-27 WO disclosed
EP-1611166-A2 BUILDING SEALANT COMPOSITION Bridgestone Corporation (JP) 2006-01-04 EP disclosed
WO-2004090060-A2 BUILDING SEALANT COMPOSITION BRIDGESTONE CORPORATION (JP) 2004-10-21 WO disclosed
US-6737470-B1 POLYCONJUGATED DIENE WITH TRIALKOXYSILANE TERMINAL GROUPS; LOW POLYDISPERSITY; LOW COST; SINGLE PACKAGE BRIDGESTONE CORPORATION (JP) 2004-05-18 US disclosed